FibroBiologics, Inc. (NASDAQ:FBLG)
| Market Cap | 2.27M-89.5% |
| Revenue (ttm) | 0 |
| Net Income | -18.14M-37.2% |
| EPS | -6.00+16.5% |
| Shares Out | 2.10M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 41,534.518 |
| Open | 1.12 |
| Previous Close | 1.14 |
| Day's Range | 1.05 - 1.13 |
| 52-Week Range | 0.62 - 10.28 |
| Beta | 1.22 |
| Analysts | Buy |
| Price Target | 180.00(+16489.86%) |
| Earnings Date | Oct 30, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About FBLG
FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage investigations are underway for CYTER915, aimed at restoring or enhancing thymus and/or spleen function; CYPS317, for psoriasis; and TCB190, designed to combat specific cancers. FibroBiologics was founded in 2021 and is situated in Houston, Texas.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$FBLG stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in FBLG holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by FBLG's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
FBLG Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New FBLG patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to FBLG from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in FBLG
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $47.76K |
Estimated from each fund’s disclosed top holdings × AUM
FBLG Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from FBLG’s recent data — informational, not investment advice